XERS - Xeris Biopharma Holdings, Inc.

QQQ $ 454.82 $ -2.05 (-0.45 %)

DIA $ 398.57 $ -6.00 (-1.51 %)

SPY $ 530.36 $ -3.87 (-0.73 %)

TLT $ 91.26 $ -0.59 (-0.64 %)

GLD $ 225.37 $ -4.39 (-1.99 %)

Previous Close

$ 1.95

Open

$ 1.99

Bid

$ 1.94 x 2,200

Ask

$ 1.96 x 100

Day's Range

$ 1.92 - $ 2.00

52 Week Range

$ 1.46 - $ 3.26

Volume

910,762

Average Volume

Market Cap

274M

Beta (5Y Monthly)

$ 1.52

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-06-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	03-08-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-10-2022	06-30-2022	10-Q
9	05-11-2022	03-31-2022	10-Q
10	03-11-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

socket-mobile-and-3-other-stocks-under-3-insiders-are-buying

Socket Mobile And 3 Other Stocks Under $3 ...
05/13/2024 12:51:16

Piper Sandler Reiterates Overweight on Xer...
05/10/2024 13:39:41

Piper Sandler analyst David Amsellem reiterates Xeris Biopharma Holdings (NASDAQ:XERS) with a Overweight and lowers the pric...

Xeris Biopharma Raises FY24 Total Revenue ...
05/09/2024 11:09:50

Xeris Biopharma Holdings Q1 EPS $(0.14) Mi...
05/09/2024 11:05:54

Xeris Biopharma Holdings (NASDAQ:XERS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estima...

Why Are Xeris Biopharma Shares Moving Monday?
05/06/2024 15:37:53

Xeris Biopharma shares are up Monday after the company announced an exclusive worldwide collaboration and license agreement wit...

Xeris Biopharma Enters Into an Exclusive W...
05/06/2024 11:01:19

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patient lives ...

Oppenheimer Initiates Coverage On Xeris Bi...
03/28/2024 10:51:31

Oppenheimer analyst Leland Gershell initiates coverage on Xeris Biopharma Holdings (NASDAQ:XERS) with a Outperform rating an...

HC Wainwright & Co. Maintains Buy on Xeris...
03/07/2024 11:13:24

HC Wainwright & Co. analyst Oren Livnat maintains Xeris Biopharma Holdings (NASDAQ:XERS) with a Buy and raises the price...

Xeris Biopharma Expects 2024 Revenue Of $1...
03/06/2024 12:08:05

Xeris Biopharma Holdings Q4 GAAP EPS $(0.1...
03/06/2024 12:04:05

Xeris Biopharma Holdings (NASDAQ:XERS) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate....

Xeris Refinances Its $150M Senior Secured ...
03/06/2024 12:01:54

Earnings Scheduled For March 6, 2024
03/06/2024 10:00:02

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

Earnings Outlook For Xeris Biopharma Holdings
03/05/2024 17:01:30

why-wd-40-shares-are-trading-higher-by-over-17-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why WD-40 Shares Are Trading Higher By Ove...
01/10/2024 18:06:18

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected ...

Xeris Biopharma Enters Into An Exclusive W...
01/10/2024 13:02:57

Lamb Weston Posts Upbeat Results, Joins Om...
01/04/2024 15:12:36

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdin...

Xeris Biopharma Sees FY23 Revenue At High ...
01/04/2024 12:12:25

HC Wainwright & Co. Maintains Buy on Xeris...
11/13/2023 23:27:05

HC Wainwright & Co. analyst Oren Livnat maintains Xeris Biopharma Holdings (NASDAQ:XERS) with a Buy and lowers the price...

Piper Sandler Maintains Overweight on Xeri...
11/10/2023 22:21:20

Piper Sandler analyst David Amsellem maintains Xeris Biopharma Holdings (NASDAQ:XERS) with a Overweight and lowers the price...

Piper Sandler Maintains Overweight on Xeri...
11/10/2023 22:20:59

Piper Sandler analyst David Amsellem maintains Xeris Biopharma Holdings (NASDAQ:XERS) with a Overweight and lowers the price...